Tekla Capital Management LLC - FOAMIX PHARMACEUTICALS LTD ownership

FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 57 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of FOAMIX PHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2019$1,002,000
+9.6%
300,7810.0%0.04%
-5.0%
Q3 2019$914,000
+27.7%
300,7810.0%0.04%
+37.9%
Q2 2019$716,000
-36.5%
300,7810.0%0.03%
-37.0%
Q1 2019$1,128,000
-47.7%
300,781
-50.0%
0.05%
-50.0%
Q4 2018$2,158,000
-48.2%
601,205
-17.3%
0.09%
-39.1%
Q3 2018$4,167,000
-10.6%
727,205
-21.8%
0.15%
-14.7%
Q2 2018$4,661,000
-2.3%
930,3980.0%0.18%
-4.8%
Q1 2018$4,773,000
-14.6%
930,3980.0%0.19%
-13.9%
Q4 2017$5,592,000
+8.3%
930,3980.0%0.22%
+16.8%
Q3 2017$5,164,000
+19.6%
930,3980.0%0.18%
+15.6%
Q2 2017$4,317,000
-6.3%
930,3980.0%0.16%
-10.6%
Q1 2017$4,605,000
-55.4%
930,3980.0%0.18%
-59.3%
Q4 2016$10,327,000
+15.4%
930,398
-3.7%
0.44%
+27.9%
Q3 2016$8,946,000
+45.8%
966,0650.0%0.34%
+37.6%
Q2 2016$6,135,000
-2.6%
966,0650.0%0.25%
-6.7%
Q1 2016$6,299,000
+19.1%
966,065
+48.1%
0.27%
+39.6%
Q4 2015$5,289,000
+17.6%
652,145
+6.3%
0.19%
+18.5%
Q3 2015$4,498,000
+6.1%
613,577
+48.3%
0.16%
+5.9%
Q2 2015$4,241,000413,8000.15%
Other shareholders
FOAMIX PHARMACEUTICALS LTD shareholders Q2 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 4,781,708$28,738,0004.90%
DSC Advisors, L.P. 1,187,604$7,138,0004.14%
Opaleye Management Inc. 960,000$5,769,0001.85%
DAFNA Capital Management LLC 352,741$2,120,0001.14%
Vivo Capital, LLC 855,000$5,139,0001.10%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 382,838$2,301,0000.81%
SENZAR ASSET MANAGEMENT, LLC 377,397$2,268,0000.58%
Sio Capital Management, LLC 131,200$789,0000.44%
Perceptive Advisors 1,117,324$6,715,0000.22%
Tekla Capital Management LLC 930,398$5,592,0000.22%
View complete list of FOAMIX PHARMACEUTICALS LTD shareholders